About

Built by NHS market access specialists.

Vima Access is a product of Vima Clinical Ltd, a UK company founded in 2021, singularly focused on primary care market access intelligence for pharmaceutical companies operating in England.

Founder note

Why we built it.

Vivek Patel, founder of Vima Clinical Ltd

After years working on NHS primary care market access, through Oberoi Consulting and earlier, the same gap kept showing up. No single tool gives a complete picture of where a drug stands in the system. Pharma teams stitch together IQVIA, Datapharm, OpenPrescribing, internal trackers, and field intelligence to answer questions that should take a single search.

Vima Access is the platform we wished we’d had. It brings the things you actually need to know about a drug into one record: regulatory classification, prescribing trends, ICB formulary status, clinical system listings, wholesaler catalogue listings, and reimbursement.

But the data layer is necessary, not sufficient. Most market access teams already piece together data from IQVIA, Datapharm, and OpenPrescribing. What they do not have is a single place to act on it: track a launch end to end, propose a formulary change with audit trail, raise a ticket on a wholesaler listing issue. Vima Access is built to be both layers in one.

We’ve kept it focused. Primary care, England, six panels, four workflows. We don’t do hospital, we don’t do other countries, and we don’t pad the platform with features that aren’t directly load-bearing for market access decisions.

Vivek PatelFounder, Vima Clinical Ltd · MRPharmS
What we believe

Three principles that shape the platform.

01
Curated, not crawled

Every formulary record, system listing, and wholesaler catalogue entry is reviewed by an analyst before it’s visible to clients. No scraped, unverified data. Every record carries a last-verified date and a verifier.

02
Primary care, England, depth over breadth

We don’t cover hospital, secondary care, or other countries. The platform’s narrow focus is what makes the depth of intelligence possible, and useful for the teams who buy it.

03
Sources visible everywhere

Every data point links back to its source: formulary PDFs, NHSBSA pages, ODS records. Pharma users can verify any claim themselves in one click. Trust through transparency, not assertion.

How we operate

What you would expect from a system of record.

Three commitments that make the platform usable for auditable, regulated work. The same three operate behind every page of data and every workflow.

Append-only audit log
Every record change is captured with actor, before, after, and timestamp. Nothing is silently overwritten.
Ingest health surface
TRUD dm+d and NHSBSA EPD pipelines surface a green/amber/red status on the admin home. When something stalls, we know first.
Atomic approve transactions
When Vima approves a formulary proposal, the write to the live entry and the proposal status update happen in a single Postgres transaction. No half-applied state.
Data sources

Where the data comes from.

dm+d via NHS TRUD
Drug names, classifications, BNF codes, formulations, controlled-drug status.
Weekly
NHSBSA EPD
National, ICB, PCN, and practice-level prescribing volume and cost.
Monthly · ~2 mo publication lag
NHS ODS
Practice-level clinical system type (EMIS / SystmOne / Vision / ProScript) and list size.
Quarterly
NHSBSA Drug Tariff
Reimbursement category, list price, ACBS approval, current concession price.
Monthly
ICB formulary publications
Listed / Restricted / Not Listed status across all 42 ICBs. Source URL on every record.
Reviewed quarterly
Clinical system intelligence
EMIS / SystmOne / Vision / ProScript listing status per drug, per system. Proprietary to Vima Clinical.
As changes occur · Quarterly wholesaler audit

See your portfolio in Vima Access.

Send us the products you’d want to see. We’ll prepare a tailored demo with real NHS data, typically within five working days.

Request a demo →